| Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study. | |
| | |
MedLine Citation:
|
PMID: 21192314 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Light transmission aggregation (LTA) is considered the reference method to identify residual platelet reactivity (RPR) in high-risk patients with coronary artery disease on clopidogrel treatment. An international standardization of this technique is still ongoing and different concentrations of adenosine diphosphate (ADP) as the agonist for LTA have been used to evaluate the inhibitory effect of clopidogrel treatment. To evaluate RPR, LTA was performed using different ADP concentrations (2, 5, 10, and 20 μmol/L) in 466 high-risk patients with coronary artery disease on dual antiplatelet therapy who underwent percutaneous coronary intervention and in 46 healthy subjects. A VerifyNow P2Y12 assay was assessed as a point-of care system. Imprecision studies showed higher coefficients of variation for LTA by 2 and 5 μmol/L ADP (healthy subjects: 4.7% and 3.9%; patients: 6.8% and 5.2%, respectively) in comparison with those obtained determining LTA using 10 and 20 μmol/L ADP (healthy subjects: 2.2% and 2.3%; patients: 2.7% and 3.1%, respectively). In patients, a significant difference (P < 0.0001) between mean values of LTA obtained with all ADP concentrations was found, even if LTA data were significantly correlated (at least: rho = 0.88, P < 0.0001). However, data from 10 and 20 μmol/L ADP LTA were very similar and highly concordant (k = 95.9%). All agreements were significant (for all P < 0.0001), in particular the agreement between 10 and 20 μmol/L ADP LTA was very good (k = 0.86, P < 0.0001). A moderate agreement between VerifyNow and both 10 and 20 μmol/L ADP LTA was observed. LTA by 10 and 20 μmol/L ADP gave equivalent percentages of aggregation and highly concordant results in terms of RPR in patients with coronary artery disease on clopidogrel. Significant concordant results were observed between both 10 and 20 μM ADP LTA and VerifyNow. This suggests that a concentration of 10 μmol/L ADP may be considered adequate for the identification of RPR of patients on clopidogrel and should be preferred for standardization LTA. |
| | |
Authors:
|
Rita Paniccia; Emilia Antonucci; Niccolò Maggini; Marco Miranda; Eloisa Romano; Anna Maria Gori; Rossella Marcucci; Domenico Prisco; Rosanna Abbate |
Related Documents
:
|
7266704 - Complement and glomerular disease - a natural history study. 15495244 - Lymphoma-associated paraneoplastic angioedema with normal c1-inhibitor activity: does d... 9517764 - Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia a... 8379684 - Autoantibodies to cartilage collagens in relapsing polychondritis. 16651864 - Inherited abnormalities of fibrinogen: 10-year clinical experience of an italian group. 20692184 - The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Therapeutic drug monitoring Volume: 33 ISSN: 1536-3694 ISO Abbreviation: Ther Drug Monit Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7909660 Medline TA: Ther Drug Monit Country: United States |
Other Details:
|
Languages: eng Pagination: 94-8 Citation Subset: IM |
Affiliation:
|
Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Florence, Italy. rita.paniccia@unifi.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.
Next Document: Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in child...